REN and hypertensive disorder: Surgical patients most at risk of sustaining myocardial injury and subsequent complications4 after noncardiac surgery5,6 are commonly prescribed renin–angiotensin system inhibitors (RASi) for cardiometabolic disease and hypertension.7